产品封面图
文献支持

pET303-CT-His质粒

收藏
  • ¥1158
  • LSM Bio
  • 进口
  • PVT10587
  • 2026年01月20日
    avatar
  • 企业认证

    点击 QQ 联系

    • 详细信息
    • 文献和实验
    • 技术资料
    • 保存条件

      负20摄氏度

    • 保质期

      3个月

    • 英文名

      pET303-CT-His

    • 库存

      100

    • 供应商

      LSMBIO

    • 规格

      2ug

    pET303-CT-His


    PVT10587   2ug

     

    pET303-CT-His Description

    pET303-CT-His is an Escherichia coli pET expression plasmid.

     

    Alias: Pet303-ct-his
    Promoter: T7/lac promoter
    Replicator: ColE1 ori,f1 Ori
    Terminator: T7 Terminator
    plasmid classification: Escherichia coli carrier; Pet Series Expression plasmid
    Plasmid Size: 5369bp
    plasmid Label: c-6xhis
    prokaryotic Resistance: ampicillin amp
    Cloned strain: Escherichia coli dh5α
    Culture conditions: 37 鈩? Aerobic, LB
    Expression host: Escherichia coli BL21 (DE3)
    Culture conditions: 37 鈩? Aerobic, LB
    Induction mode: IPTG or lactose and its analogues
    5 ' Sequencing primer: T7:TAATACGACTCACTATAGGG 3 ' Sequencing primer: T7-TER:TGCTAGTTATTGCTCAGCGG

     

    The Champion pET302/NT-His and pET303/CT-His Vector Kit is designed for cloning a gene of interest via restriction enzyme(s) and ligase (REaL) and subsequent high-level expression from the strong bacteriophage T7 promoter. In addition to the T7 promoter, each vector contains only the necessary functional elements and an N- or C-terminal 6xHis tag (pET302/NT-His and pET303/CT-His, respectively) for convenient purification and detection (Figure 1). Expression levels obtained from these vectors may be higher than those obtained from another suppliers pET vector (Figure 2). To maximize expression, use with MagicMedia E. coli Expression Medium.

     

    pET303-CT-His Multiple cloning site

    pET303-CT-His-vector

     

     

    pET303-CT-His Sequence

    LOCUS       Exported                5369 bp ds-DNA     circular SYN 23-7-2015
    DEFINITION  synthetic circular DNA
    KEYWORDS    Untitled 2
    SOURCE      synthetic DNA construct
      ORGANISM  synthetic DNA construct
    REFERENCE   1  (bases 1 to 5369)
      AUTHORS   Trial User
      TITLE     Direct Submission
      JOURNAL   Exported 2015-7-23  
    FEATURES             Location/Qualifiers
         source          1..5369
                         /organism="synthetic DNA construct"
                         /mol_type="other DNA"
         promoter        20..38
                         /note="T7 promoter"
                         /note="promoter for bacteriophage T7 RNA polymerase"
         protein_bind    39..63
                         /bound_moiety="lac repressor encoded by lacI"
                         /note="lac operator"
                         /note="The lac repressor binds to the lac operator to
                         inhibit transcription in E. coli. This inhibition can be
                         relieved by adding lactose or
                         isopropyl-beta-D-thiogalactopyranoside (IPTG)."
         RBS             79..99
                         /note="efficient ribosome binding site from bacteriophage
                         T7 gene 10 (Olins and Rangwala, 1989)"
         CDS             119..136
                         /codon_start=1
                         /product="6xHis affinity tag"
                         /note="6xHis"
                         /translation="HHHHHH"
         terminator      203..250
                         /note="T7 terminator"
                         /note="transcription terminator for bacteriophage T7 RNA
                         polymerase"
         rep_origin      287..742
                         /direction=RIGHT
                         /note="f1 ori"
                         /note="f1 bacteriophage origin of replication; arrow
                         indicates direction of (+) strand synthesis"
         promoter        769..873
                         /gene="bla"
                         /note="AmpR promoter"
         CDS             874..1734
                         /codon_start=1
                         /gene="bla"
                         /product="beta-lactamase"
                         /note="AmpR"
                         /note="confers resistance to ampicillin, carbenicillin, and
                         related antibiotics"
                         /translation="MSIQHFRVALIPFFAAFCLPVFAHPETLVKVKDAEDQLGARVGYI
                         ELDLNSGKILESFRPEERFPMMSTFKVLLCGAVLSRIDAGQEQLGRRIHYSQNDLVEYS
                         PVTEKHLTDGMTVRELCSAAITMSDNTAANLLLTTIGGPKELTAFLHNMGDHVTRLDRW
                         EPELNEAIPNDERDTTMPAAMATTLRKLLTGELLTLASRQQLIDWMEADKVAGPLLRSA
                         LPAGWFIADKSGAGERGSRGIIAALGPDGKPSRIVVIYTTGSQATMDERNRQIAEIGAS
                         LIKHW"
         rep_origin      1905..2493
                         /direction=RIGHT
                         /note="ori"
                         /note="high-copy-number ColE1/pMB1/pBR322/pUC origin of
                         replication"
         misc_feature    2679..2818
                         /note="bom"
                         /note="basis of mobility region from pBR322"
         CDS             complement(2920..3111)
                         /codon_start=1
                         /gene="rop"
                         /product="Rop protein, which maintains plasmids at low copy
                         number"
                         /note="rop"
                         /translation="MTKQEKTALNMARFIRSQTLTLLEKLNELDADEQADICESLHDHA
                         DELYRSCLARFGDDGENL"
         CDS             complement(3920..5002)
                         /codon_start=1
                         /gene="lacI"
                         /product="lac repressor"
                         /note="lacI"
                         /note="The lac repressor binds to the lac operator to
                         inhibit transcription in E. coli. This inhibition can be
                         relieved by adding lactose or
                         isopropyl-beta-D-thiogalactopyranoside (IPTG)."
                         /translation="MKPVTLYDVAEYAGVSYQTVSRVVNQASHVSAKTREKVEAAMAEL
                         NYIPNRVAQQLAGKQSLLIGVATSSLALHAPSQIVAAIKSRADQLGASVVVSMVERSGV
                         EACKAAVHNLLAQRVSGLIINYPLDDQDAIAVEAACTNVPALFLDVSDQTPINSIIFSH
                         EDGTRLGVEHLVALGHQQIALLAGPLSSVSARLRLAGWHKYLTRNQIQPIAEREGDWSA
                         MSGFQQTMQMLNEGIVPTAMLVANDQMALGAMRAITESGLRVGADISVVGYDDTEDSSC
                         YIPPLTTIKQDFRLLGQTSVDRLLQLSQGQAVKGNQLLPVSLVKRKTTLAPNTQTASPR
                         ALADSLMQLARQVSRLESGQ"
         promoter        complement(5003..5080)
                         /gene="lacI"
                         /note="lacI promoter"
    ORIGIN
            1 gatctcgatc ccgcgaaatt aatacgactc actatagggg aattgtgagc ggataacaat
           61 tcccctctag taataatttt gtttaacttt aagaaggagg tctagaatgc atctcgagca
          121 ccaccaccac caccactgag atccggctgc taacaaagcc cgaaaggaag ctgagttggc
          181 tgctgccacc gctgagcaat aactagcata accccttggg gcctctaaac gggtcttgag
          241 gggttttttg ctgaaaggag gaactatatc cggattggcg aatgggacgc gccctgtagc
          301 ggcgcattaa gcgcggcggg tgtggtggtt acgcgcagcg tgaccgctac acttgccagc
          361 gccctagcgc ccgctccttt cgctttcttc ccttcctttc tcgccacgtt cgccggcttt
          421 ccccgtcaag ctctaaatcg ggggctccct ttagggttcc gatttagtgc tttacggcac
          481 ctcgacccca aaaaacttga ttagggtgat ggttcacgta gtgggccatc gccctgatag

    风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。

    图标文献和实验
    该产品被引用文献
    Upregulation of Antioxidant Capacity and Nucleotide Precursor Availability Suffices for Oncogenic Transformation Author:YangZhang1YiXu1WenyunLu23Jonathan M.Ghergurovich24LiliGuo56Ian A.Blair5Joshua D.Rabinowitz23XiaoluYang17 Received 22 January 2020, Revised 4 August 2020, Accepted 30 September 2020, Available online 6 November 2020. Published: November 6, 2020 Cell Metabolism Available online 6 November 2020 In Press doi: doi.org/10.1016/j.cmet.2020.10.002
    相关实验
    • Imaging Cancer in Mice by PET, CT, and Combined PETCT

      of murine tumors by positron emission tomography (PET), computed tomography (CT), and combined PET?CT. Curr. Protoc. Mouse Biol. 1:85?103. © 2011 by John Wiley & Sons, Inc. Keywords: cancer; mouse models; positron electron tomography

    • PET and PET-CT of Lung Cancer

      , either alone or in combination with chemo- or radiotherapy at the more advanced stages. However, many patients present with metastatic disease at the time of diagnosis. Both computed tomography (CT) and positron emission tomography (PET) using fluorodeoxyglucose (FDG) play

    • PET and PET/CT in the Management of Thyroid Cancer

      The introduction of PET(-CT) has brought about a major paradigm shift in the management of thyroid carcinoma, especially from the diagnostic standpoint. From the viewpoint of patient management, the areas where it has made significant impact

    图标技术资料

    暂无技术资料 索取技术资料

    同类产品报价

    产品名称
    产品价格
    公司名称
    报价日期
    ¥800
    上海钰博生物科技有限公司
    2025年07月07日询价
    ¥1200
    上海晶风生物科技有限公司
    2025年05月21日询价
    ¥1080
    武汉维克赛思科技有限公司
    2025年09月26日询价
    ¥680
    温州科淼生物科技有限公司
    2025年07月11日询价
    询价
    上海北诺生物科技有限公司
    2025年07月15日询价
    文献支持
    pET303-CT-His质粒
    ¥1158